The Swoop portable MRI system showed 92% agreement with traditional MRI scans and was four times more likely to be chosen by ...
The U.S. Food and Drug Administration (FDA) stated on Thursday that it is requiring an additional MRI scan for Alzheimer's patients receiving Leqembi (lecanemab), citing safety concerns over a rare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results